Prevalence and risk factors of non-alcoholic fatty liver disease (NAFLD) in polycystic ovary syndrome: a cross-sectional study

Prevalence and risk factors of non-alcoholic fatty liver disease (NAFLD) in polycystic ovary syndrome: a cross-sectional study - Prevalence and risk factors of non-alcoholic fatty liver disease (NAFLD) in polycystic ovary syndrome(PR-NAFLD)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032783

Enrollment

200

Registered

2018-05-30

Start date

2018-05-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Meet all of the following: 1) Women visited the Department of Gynecology in our Center from January 1, 2000 to September 30, 2016. 2) Women with confirmed diagnosis of polycystic ovary syndrome. 3) ALT data available

Exclusion criteria

Exclusion criteria: Fall under any of the following: 1) Missing data of body height, weight and BMI 2) Women with history of liver diseases 3) Pregnant women

Design outcomes

Primary

Measure	Time frame
Prevalence of NAFLD (Alanine aminotransferase (ALT) > 19 IU/L)	—

Secondary

Measure	Time frame
Risk factors of NAFLD	—

Countries

Japan

Contacts

Public ContactSatomi Minato

Clinical Research Institute, National Hospital Organization Kyoto Medical Center Department of Preventive Medicine

sminato@kyotolan.hosp.go.jp+81-75-641-9161

Outcome results